Immune cell labelling and tracking: implications for adoptive cell transfer therapies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2365-421X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immune cell labelling and tracking: implications for adoptive cell transfer therapies ; volume:6 ; number:1 ; day:3 ; month:2 ; year:2021 ; pages:1-19 ; date:12.2021
EJNMMI radiopharmacy and chemistry ; 6, Heft 1 (3.2.2021), 1-19, 12.2021

Creator: Galli, Filippo
Varani, Michela
Lauri, Chiara
Silveri, Guido Gentiloni
Onofrio, Livia
Signore, Alberto

Contributor: SpringerLink (Online service)

DOI: 10.1186/s41181-020-00116-7

URN: urn:nbn:de:101:1-2021032711530220321551

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Galli, Filippo
Varani, Michela
Lauri, Chiara
Silveri, Guido Gentiloni
Onofrio, Livia
Signore, Alberto
SpringerLink (Online service)

Other Objects (12)

CRISPR–Cas9 applications in T cells and adoptive T cell therapies

High-throughput screening for optimizing adoptive T cell therapies

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

Adoptive cellular therapies: the current landscape

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies

Adoptive T-cell therapy for Leukemia

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Adoptive cell transfer therapy for hepatocellular carcinoma

Hochschulschrift

Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells

CRISPR–Cas9 applications in T cells and adoptive T cell therapies

High-throughput screening for optimizing adoptive T cell therapies

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

Adoptive cellular therapies: the current landscape

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies

Adoptive T-cell therapy for Leukemia

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Adoptive cell transfer therapy for hepatocellular carcinoma

Hochschulschrift

Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells

CRISPR–Cas9 applications in T cells and adoptive T cell therapies

High-throughput screening for optimizing adoptive T cell therapies

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

Adoptive cellular therapies: the current landscape

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies

Adoptive T-cell therapy for Leukemia

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Adoptive cell transfer therapy for hepatocellular carcinoma

Hochschulschrift

Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immune cell labelling and tracking: implications for adoptive cell transfer therapies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

CRISPR–Cas9 applications in T cells and adoptive T cell therapies

High-throughput screening for optimizing adoptive T cell therapies

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

Adoptive cellular therapies: the current landscape

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies

Adoptive T-cell therapy for Leukemia

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Adoptive cell transfer therapy for hepatocellular carcinoma

Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells

CRISPR–Cas9 applications in T cells and adoptive T cell therapies

High-throughput screening for optimizing adoptive T cell therapies

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

Adoptive cellular therapies: the current landscape

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies

Adoptive T-cell therapy for Leukemia

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Adoptive cell transfer therapy for hepatocellular carcinoma

Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells

CRISPR–Cas9 applications in T cells and adoptive T cell therapies

High-throughput screening for optimizing adoptive T cell therapies

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

Adoptive cellular therapies: the current landscape

Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies

Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies

Adoptive T-cell therapy for Leukemia

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Adoptive cell transfer therapy for hepatocellular carcinoma

Improving adoptive T cell therapies of cancer by ectopic expression of miR181a to repress inhibitory phosphatases

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells

Related objects

Reset password